drugset / Trial / NCT07107230
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
NaSequentialOpen-labelTreatment
Summary
The purpose of this study is to determine recommended phase 2 doses (RP2Ds) of JNJ-95437446 in Part 1, and to further evaluate the safety of the RP2Ds in participants with advanced solid tumors in Part 2.
Timeline
- Start
- 2025-07-15
- Primary completion
- 2027-11-18
- Completion
- 2028-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-95437446 | Unknown | — | — |